Chemoinformaics analysis of BUT-2-ENOIC-ACID-METHYL-ESTER
Molecular Weight | 87.098 | nRot | 2 |
Heavy Atom Molecular Weight | 80.042 | nRig | 1 |
Exact Molecular Weight | 87.0441 | nRing | 0 |
Solubility: LogS | 0.363 | nHRing | 0 |
Solubility: LogP | 0.277 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 12.9516 |
nHD | 1 | BPOL | 7.89045 |
QED | 0.533 |
Synth | 3.698 |
Natural Product Likeliness | 0.232 |
NR-PPAR-gamma | 0.637 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.005 |
HIA | 0.008 |
CACO-2 | -4.988 |
MDCK | 0.000105797 |
BBB | 0.896 |
PPB | 0.429885 |
VDSS | 0.268 |
FU | 0.602368 |
CYP1A2-inh | 0.017 |
CYP1A2-sub | 0.111 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.098 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.929 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.344 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.057 |
CL | 5.728 |
T12 | 0.865 |
hERG | 0.006 |
Ames | 0.04 |
ROA | 0.354 |
SkinSen | 0.671 |
Carcinogencity | 0.726 |
EI | 0.994 |
Respiratory | 0.262 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.985927 |